Nifekalant

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nifekalant
Nifekalant.png
Systematic (IUPAC) name
6-[(2-{(2-hydroxyethyl)[3-(4-nitrophenyl)propyl]amino}ethyl)amino]-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
  • Prescription only
Routes IV
Identifiers
CAS number 130636-43-0 YesY
ATC code None
PubChem CID 4486
ChemSpider 4331
UNII 5VZ7GZM43E YesY
Chemical data
Formula C19H27N5O5 
Mol. mass 405.44 g/mol
 YesY (what is this?)  (verify)

Nifekalant (INN) is a class III antiarrhythmic agent approved in Japan for the treatment of arrhythmias and ventricular tachycardia.[1] It has the brand name Shinbit.

References[edit]

  1. ^ Oyabe A, Sano H (February 2002). "[Pharmacological and clinical profile of nifekalant (shinbit injection), a class III antiarrhythmic drug]" ([dead link]Scholar search). Nippon Yakurigaku Zasshi (in Japanese) 119 (2): 103–9. doi:10.1254/fpj.119.103. PMID 11862758.